Le Lézard
Classified in: Health, Science and technology

Defining, Designing and Deploying Digital Biomarkers in Clinical Trials, Upcoming Webinar Hosted by Xtalks


TORONTO, Sept. 25, 2020 /PRNewswire-PRWeb/ -- Many drug development sponsors are interested in understanding how a digital biomarker strategy can improve patient-centricity their trial. However, may feel uncertain about where ? and sometimes even why ? to start. From concerns surrounding regulatory acceptance to defining digital endpoints and deployment plans and digital data collection, there are many factors to consider before incorporating new tools and processes into a clinical trial.

This educational webinar is ideal for drug development sponsors that want to learn about the role of digital biomarkers in clinical trials and hear from several thought leaders as they discuss the key concerns with digital biomarker technologies, their implementation and regulatory acceptance. With a focus on strategic design and considerations for creating digital endpoints as part of an overarching deployment plan, the presenters will also cover many of the key pillars in the adoption and implementation of digital devices in a today's "new normal" with decentralized or hybrid clinical trial elements.

Register today to be a part of this timely and highly relevant discussion that will also offer attendees a chance to pose their own questions and get real-time responses from several thought leaders.

Join Jennifer Goldsack, MChem, MA, MBA, Executive Director, Digital Medicine Society (DiMe), Christian Knaus, Senior Director, Client Development, SnapIoT Inc., Cristina Green, Executive Director, Decentralized Clinical Trials, Covance and Jane Myles , Director, Decentralized Trials Implementation, Covance in a live webinar on Wednesday, October 7, 2020 at 10am EDT (3pm BST/UK).

For more information or to register for this event, visit Defining, Designing and Deploying Digital Biomarkers in Clinical Trials.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

 

SOURCE Xtalks


These press releases may also interest you

at 06:35
Why Should I Worry About Entropy? Entropy, also known as randomness, is the anchor beneath much of the world's security. Poor-quality entropy compromises security, while low speed entropy compromises performance, and all too often organizations must...

at 06:35
BiomX Inc. , a clinical stage company developing natural and engineered phage therapies that target specific pathogenic bacteria, today presented preclinical data from its phage panel for the treatment of inflammatory bowel disease at the Infectious...

at 06:35
NICE today announced that Midland States Bank, a wholly-owned subsidiary of Midland States Bancorp, Inc. , has selected NICE Satmetrix to unify its growth strategies, culture, and operations around its mission to continue a customer-centric culture....

at 06:35
Accenture has completed its acquisition of N3, an Atlanta-based business-to-business (B2B) sales firm that combines specialized talent with artificial intelligence (AI) and machine learning (ML) capabilities to enable smarter, more efficient sales...

at 06:35
ProMIS Neurosciences, Inc. , a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, released a white paper today that offers...

at 06:30
ImagineAR (IP:CSE) (IPNFF:OTCQB) an Augmented Reality Company that enables businesses to instantly create their own mobile phone AR campaigns, is pleased to announce its first-ever mobile WebAR Retail Project launching in December 2020.  This is a...



News published on 25 september 2020 at 08:30 and distributed by: